Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Some information in this page has been claimed confidential.

Administrative data

acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
22 September - 18 October 1988
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP compliant, guideline study, available as unpublished report, no restictions, fully adequate for assessment.
Reason / purpose for cross-reference:
read-across: supporting information

Data source

Reference Type:
study report
Report date:

Materials and methods

Test guideline
according to guideline
OECD Guideline 401 (Acute Oral Toxicity)
Principles of method if other than guideline:
Doses of DCPD 75%: 500, 794, 1260 & 2000 mg/kg/bw
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:

Test material

Constituent 1
Details on test material:
- Name of test material (as cited in study report): DCPD 75%
- Physical state: clear, yellow-coloured liquid
- Composition of test material, percentage of components: 71.1% endo dicyclopentadiene, 0.8% exo dicyclopentadiene, 1.4% m-bicyclozonadiene, 15.2% CPD-MCPD codimers, 0.3% tricyclopentadiene, 1.3% CPD-butadiene codimer, 0.3% CPD-piperylene codimer, 0.3% CPD-isoprene codimer, <0.1% benzene , remainder misc. hydrocarbons.
- Specific gravity: 0.971
- Storage condition of test material: room temperature

Test animals

Details on test animals or test system and environmental conditions:
- Source: Interfauna (UK) Ltd., Wyton, Huntingdon, Cambridgeshire
- Age at study initiation: 5-8 weeks
- Weight at study initiation: males 120-146 g; females 120-150 g
- Fasting period before study: overnight
- Housing: In groups of up to 5, sexes separately in solid floor polypropylene cages with sawdust bedding.
- Diet: Rat and Mouse Expanded Diet No. 1 (Special Diet Services Ltd., Witham, Essex, UK) ad libitum (except for overnight fast immediately prior to dosing and approximately 2 hours after dosing)
- Water: Mains drinking water ad libitum
- Acclimation period: At least 5 days

- Temperature (°C): 20-21
- Humidity (%): 45-68
- Air changes (per hr): approx 15
- Photoperiod (hrs dark / hrs light): 12 / 12

IN-LIFE DATES: From: 22 September 1988 To: 18 October 1988

Administration / exposure

Route of administration:
oral: gavage
unchanged (no vehicle)
Details on oral exposure:
Maximum dose volume applied: 2.06 mL/kg
Minimum dose volume applied: 0.51 mL/kg
500, 794, 1260 and 2000 mg/kg
No. of animals per sex per dose:
Control animals:
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observed 1 and 4 hours after dosing and once daily thereafter. Body weights recorded on day of dosing (day 0), days 7, 14 or at death.
- Necropsy of survivors performed: yes
The acute oral LD50 and 95% confidence limits calculated using the probit method.

Results and discussion

Effect levelsopen allclose all
Key result
Dose descriptor:
Effect level:
590 mg/kg bw
95% CL:
393 - 886
Key result
Dose descriptor:
Effect level:
512 mg/kg bw
95% CL:
227 - 1 155
Key result
Dose descriptor:
Effect level:
676 mg/kg bw
95% CL:
444 - 1 030
All deaths occurred one or two days following dosing. There were 2, 4, 5 and 5 male deaths and 1, 2, 5 and 5 females deaths in the 500, 794, 1260 and 2000 mg/kg bw groups respectively.
Clinical signs:
other: Hunched posture, piloerection, lethargy and decreased respiratory rate were present in all animals during the day of dosing. Ptosis was occasionally noted in animals dosed with 794 and 1260 mg/kg during this period. All rats dosed with 2000 mg/kg had ptos
Gross pathology:
Haemorrhagic lungs, dark liver and sloughing of the non-glandular gastric epithelium was seen in decedents. No abnormalities were seen in animals killed at the end of the study.

Applicant's summary and conclusion

Interpretation of results:
other: Harmful if swallowed
Criteria used for interpretation of results: EU
The acute oral LD50 and 95% confidence limits of DCPD 75% were calculated to be 590 (393 - 886) mg/Kg bw for males and females combined; 512 (227 - 1155) mg/Kg bw for males and 676 (444 - 1030) mg/Kg bw for females.
Executive summary:

Groups of 5 male and 5 female Sprague Dawley rats (fasted overnight) were dosed by gavage at levels of 500, 794, 1260 or 2000 mg/Kg DCPD and were observed daily for 14 days after dosing. At the 4 hour observation period rats dosed with high levels of DCPD (1260 or 2000 mg/Kg bw) had hunched posture, piloerection, lethargy and decreased respiratory rate, with ptosis and occasional signs of ataxia seen in those dosed at 2000 mg/Kg bw . All rats dosed at 1260 or 2000 mg/Kg bw died one or two days after dosing. Haemorrhagic lungs, dark liver and sloughing of the non-glandular gastric epithelium was seen in decedents.

The LD50 was calculated to be 590 mg/Kg bw (male/female), 512 mg/Kg bw for males and 676 mg/Kg bw for females.